Spectral Tissue Imaging for Early Pressure Ulcer Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting pressure ulcers are subjective, unreliable, and untimely, leading to untreated inflammation that can develop into full-blown ulcers, and existing equipment struggles to objectively assess blood flow in healing tissues.

Innovation Solution

Implementing non-invasive spectral imaging (SI) to assess tissue below the skin's surface, using multispectral or hyperspectral imaging to measure SI signal intensity, and administering anatomy-specific interventions based on SI thresholds to prevent ulcer development and monitor healing.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If visual inspection is used to detect pressure ulcers, then the method is simple and non-invasive, but the detection is subjective, unreliable, and untimely

Engineering Contradiction:
Improvesimplicity of detection methodVSAvoidreliability of pressure ulcer detection
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent replaces the mechanical/visual inspection system with an optical spectroscopy system. Instead of relying on human eyes to detect skin changes, the system uses spectral imaging to objectively measure tissue characteristics through non-contact optical measurement, thereby eliminating subjectivity while maintaining non-invasiveness

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The system changes the detection parameter from visual appearance (which is subjective and late-stage) to spectral characteristics (which are objective and can detect early changes). By measuring reflectance or absorbance spectra across multiple wavelengths, the system can detect tissue damage before it becomes visually apparent, improving both reliability and timeliness

Inventive Principle:
Principle #35Parameter changes

2Device complexity

If visual inspection is used to detect pressure ulcers, then the method requires no special equipment, but it cannot detect tissue damage before visible skin breaks

Engineering Contradiction:
Improveequipment simplicityVSAvoidtiming of ulcer detection
Core Design Contradiction:
Device complexityVSLoss of time

Solution Approach 1:

The system performs preliminary detection of tissue damage by measuring spectral characteristics that change before visible skin breakdown occurs. By detecting early spectral changes in blood flow, oxygenation, or water content, the system can identify at-risk areas before ulcer formation becomes visible, enabling early intervention

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent introduces spectral imaging as an intermediary measurement that bridges the gap between normal tissue and visible ulceration. This intermediary optical measurement can detect sub-surface tissue changes without requiring the skin to break down or become visibly damaged, thus timing the detection earlier

Inventive Principle:
Principle #24Intermediary (Mediator)

3Adaptability or versatility

If universal prevention is applied to all patients, then the approach is simple and equitable, but it does not target specific anatomical sites needing intervention

Engineering Contradiction:
Improveapplicability to all patientsVSAvoidtargeted intervention capability
Core Design Contradiction:
Adaptability or versatilityVSEase of operation

Solution Approach 1:

The system applies local quality by measuring spectral characteristics at specific anatomical sites (such as sacrum, heels, elbows) where pressure ulcers are most likely to occur. Instead of treating all patients uniformly, the system identifies specific high-risk locations and applies targeted interventions only where spectral analysis indicates tissue vulnerability, thereby improving operational efficiency and intervention precision

Inventive Principle:
Principle #3Local quality

4Device complexity

If existing equipment is used to assess blood flow, then the equipment is readily available, but it cannot objectively assess blood flow in healing tissues

Engineering Contradiction:
Improveequipment availabilityVSAvoidprecision of blood flow assessment
Core Design Contradiction:
Device complexityVSMeasurement precision

Solution Approach 1:

The patent replaces imprecise mechanical or electrical blood flow measurement methods with optical spectroscopy. By using light to non-invasively measure tissue oxygenation, blood flow, and water content through spectral analysis, the system achieves objective and precise assessment of healing tissue characteristics that existing equipment cannot reliably detect

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables early detection of pressure ulcer risk and targeted interventions, reducing ulcer incidence and severity, and effectively monitoring tissue healing without visible skin damage.

Implementation Method 1

Spectral imaging (SI) allows the combination of multiple images from overlapping spectral ranges to identify targets from complex background

Methodology Applied
Scientific EffectSpectral imaging: Absorption Spectroscopy

Data Source

PatentUS20260047761A1Spectral Imaging
Publication Date: 2026.02.19 BRUIN BIOMETRICS LLC
  • US20260047761A1 patent drawing
  • US20260047761A1 patent drawing
  • US20260047761A1 patent drawing

AI summary

The present disclosure provides methods and apparatus for evaluating tissue structure in damaged or healing tissue. The present disclosure also provides methods of identifying a patient at the onset of risk of pressure ulcer or at risk of the onset of pressure ulcer, and treating the patient with anatomy-specific clinical interventions selected, based on spectral imaging (SI). The present disclosure also provides methods of stratifying groups of patients based on risk of wound development and methods of reducing incidence of tissue damage in a care facility. The present disclosure also provides methods to analyze trends of SI intensities to detect tissue damage before it is visible, and methods to compare bisymmetric SI intensities to identify damaged tissue.